Table 2. Meta-regression for the association among comorbidities and critical conditions among COVID-19 patients.
| Age (years) | Male (%) | |||
|---|---|---|---|---|
| Coefficient | P-value | Coefficient | P-value | |
| COPD | −0.020 | 0.46 | 0.010 | 0.79 | 
| CVD | 0.021 | 0.20 | −0.046 | 0.03 | 
| CVA | −0.019 | 0.76 | 0.090 | 0.40 | 
| Hypertension | −0.009 | 0.58 | −0.009 | 0.62 | 
| Diabetes | −0.039 | 0.002 | −0.002 | 0.93 | 
| Chronic liver disease | −0.023 | 0.59 | −0.079 | 0.38 | 
| Chronic kidney disease | −0.025 | 0.44 | 0.028 | 0.60 | 
| Malignancy | −0.037 | 0.15 | −0.006 | 0.92 | 
COVID-19, coronavirus disease 2019; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; CVA, cerebrovascular accident.